6,486 Studies Reviewed. 85.2% of Original Studies Found Biological Effects. The Evidence is Clear.

Electromagnetic field could protect SH-SY5Y cells against cisplatin cytotoxicity, but not MCF-7 cells.

Bioeffects Seen

Mahmoudinasab H, Saadat M. · 2018

View Original Abstract
Share:

Electromagnetic field exposure combined with cisplatin reduced the drug's cytotoxicity in SH-SY5Y cells but produced no significant change in MCF-7 cells.

Plain English Summary

Summary written for general audiences

Researchers tested four treatment combinations on MCF-7 and SH-SY5Y cells: cisplatin alone, cisplatin with morin, cisplatin with electromagnetic field, and cisplatin combined with both morin and electromagnetic field. The electromagnetic field was applied at 50 Hz and 0.50 mT using a cycle of 15 minutes field-on followed by 15 minutes field-off. The IC50 value of cisplatin in the cisplatin-plus-morin-plus-EMF treatment was significantly higher than cisplatin alone and the cisplatin-plus-morin treatment in both cell lines. In SH-SY5Y cells, most of the antioxidant genes showed upregulation with the cisplatin-plus-EMF and cisplatin-plus-morin-plus-EMF treatments, while antioxidant gene expression patterns were similar across the four treatments in MCF-7 cells.

Why This Matters

The researchers also measured the mRNA expression levels of 11 antioxidant genes across both cell lines and all four treatments. Significant differences in the number of upregulated genes were observed between different treatments in SH-SY5Y cells. The researchers suggested that the molecular mechanism behind reduced cisplatin cytotoxicity in their combinations is probably different in MCF-7 and SH-SY5Y cells.

Exposure Details

Magnetic Field
0.5 mT
Source/Device
50 Hz
Exposure Duration
15 min field-on/15 min field-off

Exposure Context

This study used 0.5 mT for magnetic fields:

Building Biology guidelines are practitioner-based limits from real-world assessments. BioInitiative Report recommendations are based on peer-reviewed science. Check Your Exposure to compare your own measurements.

Where This Falls on the Concern Scale

Study Exposure Level in ContextStudy Exposure Level in ContextThis study: 0.5 mTExtreme Concern - 5 mGFCC Limit - 2,000 mGEffects observed in the Extreme Concern range (Building Biology)This level is 3 times the FCC limit
A logarithmic frequency spectrum from 10 Hz to 100 GHz showing where this study's 50 Hz exposure sits relative to common EMF sources.Where This Frequency Sits on the EMF SpectrumELFVLFLF / MFHF / VHFUHFSHFmm10 Hz100 GHzThis study: 50 HzCell phones~1 GHzWiFi2.4 GHz5G mm28 GHzLogarithmic scale

Study Details

In this study, we tried to increase the cytotoxicity of CDDP in combination with Mor and/or EMF in MCF-7 and SH-SY5Y cells. Furthermore, we evaluate the expression levels of 11 antioxidant genes in both cell lines.

We designed four treatments: CDDP alone, “CDDP+Mor,” “CDDP+EMF,” and “CDDP+Mor+EMF.” Serial dilution...

The IC50 value of CDDP in “CDDP+Mor+EMF” treatment was significantly higher than CDDP alone and “CDD...

Cite This Study
Mahmoudinasab H, Saadat M. (2018). Electromagnetic field could protect SH-SY5Y cells against cisplatin cytotoxicity, but not MCF-7 cells. DNA Cell Biol. 37(4):330-335, 2018a.
Show BibTeX
@article{h_2018_electromagnetic_field_could_protect_415,
  author = {Mahmoudinasab H and Saadat M.},
  title = {Electromagnetic field could protect SH-SY5Y cells against cisplatin cytotoxicity, but not MCF-7 cells. },
  year = {2018},
  doi = {10.1089/dna.2017.4108},
  url = {https://www.liebertpub.com/doi/abs/10.1089/dna.2017.4108},
}

Cited By (3 papers)

Quick Questions About This Study

The field was set to 50 Hz and 0.50 mT, applied in a cycle of 15 minutes on followed by 15 minutes off.
The combination of cisplatin and EMF could protect SH-SY5Y cells from cisplatin's cytotoxicity, with no significant change observed in MCF-7 cells.
In MCF-7 cells, antioxidant gene expression patterns were similar across all four treatments, while in SH-SY5Y cells, most antioxidant genes showed upregulation with the cisplatin-plus-EMF and cisplatin-plus-morin-plus-EMF treatments.
The researchers suggested the molecular mechanism of reduced cisplatin cytotoxicity in their combinations is probably different in MCF-7 and SH-SY5Y cells.
The mRNA expression levels of antioxidant genes were determined by real-time PCR.